COMMUNIQUÉS West-GlobeNewswire

Establishment Labs to Participate in the Morgan Stanley 17th Annual Global Healthcare Conference
28/08/2019
NEW YORK, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today [...]
Autolus Therapeutics to Participate in Upcoming Investor Conferences in September
28/08/2019
LONDON, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that management will [...]
Ziopharm Oncology to Participate in the Morgan Stanley 17th Annual Global Healthcare Conference
28/08/2019
BOSTON, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (Nasdaq: ZIOP) today announced that Laurence Cooper, M.D., Ph.D., Chief Executive Officer of Ziopharm, will participate in a webcast fireside chat at [...]
Kezar Life Sciences Announces Presentations at Upcoming Investor Conferences
28/08/2019
SOUTH SAN FRANCISCO, Calif., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing novel small molecule therapeutics to treat unmet [...]
Corcept Therapeutics Announces Allowance of Additional Patent Covering the Use of Korlym to Treat Patients With Cushing’s Syndrome
28/08/2019
MENLO PARK, Calif., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) announced today that the United States Patent and Trademark Office has issued a Notice of Allowance for a patent [...]
Diversicare's Common Stock Will be Traded on the OTCQX Following the Delisting From NASDAQ
28/08/2019
BRENTWOOD, Tenn., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (NASDAQ: DVCR) was notified by The Nasdaq Stock Market LLC ("Nasdaq") that the Nasdaq Hearings Panel denied the Company’s recent [...]
CB2 Insights Reports Second Quarter Fiscal 2019 Financial Results, Sees Positive Impact from New Acquisitions
28/08/2019
Revenue Increases 14% Over the Prior Quarter; 14% Improvement in Net Income/Loss Position TORONTO, Aug. 28, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB:CBIIF) (“ CB2 ” or the “ Company ”), a leading [...]
Alder BioPharmaceuticals® to Present at Two Upcoming September Investor Conferences
28/08/2019
BOTHELL, Wash., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
Transparency notification – Gilead holds 22% of Galapagos shares
28/08/2019
Mechelen, Belgium; 28 August 2019; 22.01 CEST; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from Gilead Sciences, Inc. Pursuant to Belgian transparency [...]
Reata Appoints Manmeet S. Soni as Chief Financial Officer; Jason D. Wilson to Assume New Role as EVP, Operations
28/08/2019
IRVING, Texas, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a clinical-stage biopharmaceutical company, today announced the appointment of Manmeet S. Soni as Chief Financial Officer (CFO [...]
Ascendis Pharma A/S Reports Second Quarter 2019 Financial Results
28/08/2019
– TransCon hGH moves towards Biologics License Application submission following completion of heiGHt and fliGHt Trials – – Global reach of endocrinology rare disease programs expands – – Conference call today at 4:30 p. [...]
Trevena Advances NDA Resubmission Activities for Oliceridine
28/08/2019
— Completed enrollment in healthy volunteer QT study, topline data expected in Q4 2019 — — Completed characterization of inactive metabolite — — Remains on track to resubmit NDA in Q1 2020 — CHESTERBROOK, Pa., Aug. 28, [...]
Adverum Biotechnologies to Present 24-Week Data from First Cohort of OPTIC Trial of ADVM-022 Intravitreal Injection Gene Therapy to Treat Wet AMD at the American Academy of Ophthalmology 2019 Annual Meeting in October
28/08/2019
Dr. Szilard Kiss to Present at the Late Breaking Developments Session During the Retina Subspecialty Day Program on October 11, 2019 MENLO PARK, Calif., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. ( [...]
Align Technology to Speak at an Upcoming Financial Conference
28/08/2019
SAN JOSE, Calif., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN) today announced that the company is scheduled to speak at an upcoming financial conference. The presentation, as noted below, [...]
PROJECT HOPE PREPARES FOR AFTERMATH OF TROPICAL STORM DORIAN IN PUERTO RICO
28/08/2019
Project HOPE’s local team gears up to meet anticipated health needs Millwood, Virginia, Aug. 28, 2019 (GLOBE NEWSWIRE) -- The global health and humanitarian organization Project HOPE is actively monitoring Tropical [...]
Emerald Health Therapeutics annonce un financement de parts de débentures convertibles de 25 millions USD
28/08/2019
CE COMMUNIQUÉ DE PRESSE NE DOIT PAS ÊTRE DISTRIBUÉ AUX AGENCES DE PRESSE AMÉRICAINES ET NE DOIT PAS ÊTRE DIFFUSÉ AUX ÉTATS-UNIS VANCOUVER, Colombie-Britannique, 28 août 2019 (GLOBE NEWSWIRE) -- Emerald Health [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 juillet 2019
28/08/2019
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 juillet 2019 En application de l'article L. 233-8 II du code de commerce et de l'article 222-12-5 du règlement général de l'AMF, [...]
Inventiva secures a new European patent strengthening and extending the protection of its lead product candidate lanifibranor
28/08/2019
Inventiva secures a new European patent strengthening and extending the protection of its lead product candidate lanifibranor The latest European patent granted by the European Patent Office protects the use of [...]
Inventiva enregistre un nouveau brevet européen renforçant et étendant la protection de son candidat médicament phare lanifibranor
28/08/2019
Inventiva enregistre un nouveau brevet européen renforçant et étendant la protection de son candidat médicament phare lanifibranor Le nouveau brevet européen délivré par l’Office Européen des Brevets protège l’ [...]

Pages